Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study of the Austrian Headache Society: Monoclonal CGRP Antibodies for Migraine Prevention a Nationwide Real Life Study

NCT05281770 is registered in ClinicalTrials.gov with Austrian Migraine Registry Collaboration as lead sponsor.

NCT NCT05281770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05281770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study of the Austrian Headache Society: Monoclonal CGRP Antibodies for Migraine Prevention a Nationwide Real Life Study
Lead sponsor
Austrian Migraine Registry Collaboration
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
December 1, 2025
Enrollment
1,500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, episodic migraine, migraine, migraine with aura, migraine without aura